Arkolith/Insider Trading/ACRV/Form 4

Blume-Jensen Peter

President and CEO, DirectorAcrivon Therapeutics, Inc. (ACRV) · full profile →Form 4 · filed Feb 18, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 14, 2026Tax withholding(F)579$1.63$944314K
Feb 14, 2026Tax withholding(F)1K$1.63$2K2.1M

Transaction Codes

F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000905148-26-000934) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML